Cite
(P056) Ten-Year Outcomes of Patients With Gleason Score 9/10 Prostate Cancer Treated With Trimodality Therapy.
MLA
Wong, Andrew T., et al. “(P056) Ten-Year Outcomes of Patients With Gleason Score 9/10 Prostate Cancer Treated With Trimodality Therapy.” Oncology (08909091), vol. 29, Apr. 2015, pp. 1–2. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=135777024&authtype=sso&custid=ns315887.
APA
Wong, A. T., Sivathayalan, A., Salant, R., Harrison, L., Stewart, R., Carpenter, T., & Shasha, D. (2015). (P056) Ten-Year Outcomes of Patients With Gleason Score 9/10 Prostate Cancer Treated With Trimodality Therapy. Oncology (08909091), 29, 1–2.
Chicago
Wong, Andrew T., A. Sivathayalan, R. Salant, L. Harrison, R. Stewart, T. Carpenter, and D. Shasha. 2015. “(P056) Ten-Year Outcomes of Patients With Gleason Score 9/10 Prostate Cancer Treated With Trimodality Therapy.” Oncology (08909091) 29 (April): 1–2. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=135777024&authtype=sso&custid=ns315887.